5th International Congress on Autoimmunity, Sorrento, Italy, November 29 - December 3, 2006

TOPICS

  1. ETIOLOGY AND PATHOGENESIS
    • Somatic hypermutation in human autoantibodies
    • Innate autoimmunity and adoptive autoimmunity
    • Toll-like receptors in autoimmunity
    • Apoptosis and autoimmunity
    • Molecular signalling in apoptosis of T cell subsets
    • Vascular injury: insights gained through proteomics and genomics
    • Tracking CD4+ T cells in the pathogenesis of human autoimmune diseases
    • Effectors of autoimmune tissue injury
    • Autoimmune epitopes: autoepitopes
    • Pathogenic mechanisms involving cytokines
    • The role of interferons in the pathogenesis of lupus
    • Neurotransmitters and immunology interactions
    • Infections as a cause of autoimmune diseases
    • Role of infection in vascular injury
    • Pathogenesis of autoimmune cardiomyopathy
    • Pathogenic potential of ANCA
    • Tissue factor and autoimmunity
    • Complement and autoimmunity
    • Origins of rheumatoid arthritis

  2. GENETICS
    • Genetics of autoimmune diseases (CD4/CD25 regulatory T cells)
    • Autoimmunity predisposing genes
    • Genes involved in tolerance and autoimmunity
    • Gene expression in multiple sclerosis
    • Express yourself! Gene expression profiling in rheumatic diseases
    • Immunoglobulin gene regulation in autoimmunity
    • The genetics of SLE
    • Immunogenetics of autoimmune thyroid diseases
    • Genome wide SNP analyses on rheumatoid arthritis
    • TCR gene transfer for controlling autoimmunity

  3. MECHANISM
    • Penetration of autoantibodies into living cells
    • Role of dendritic cells in the induction of tolerance/autoimmunity
    • Chemokines and their receptors in autoimmune diseases
    • Cell adhesion molecules in arthritis and autoimmune diseases
    • Food antigens and autoimmunity
    • Environment versus genetics in autoimmunity
    • Migration of autoimmune T cells
    • Autoimmune B cells
    • B lymphocytes in autoimmune diseases
    • BlyS and anti-BlyS
    • Fc-gamma receptors
    • Immunological homunculus
    • The role of MHC/peptide tetramers for tracking autoreactive T cells
    • Mast cells and autoimmunity
    • Anti-receptor autoantibodies
    • Intrathymic expression of self-antigens
    • T cell receptor antagonism
    • Angiogenesis in arthritis
    • Anti heat shock protein 60 immunity and atherosclerosis
    • Signals for T cell activation and regulation
    • Role of innate V/S acquired autoimmune responses in human cardiomyopathies
    • Primary epitopes for MHC restricted autoimmune disorders
    • Regulatory T cells in rheumatic diseases – from bench to bedside
    • Antibody affinity maturation
    • Multiple pathways of apoptosis in naïve and memory lymphocytes
    • Regulation of cytokine production by PI3K
    • Human NK cells: their surface receptors and function
    • Atherosclerosis, angiogenesis, and autoimmunity and gamma delta T cell
    • Complement and kidney disease
    • Innate autoreactivity
    • Neutrophil alteration in autoimmune diseases
    • Molecular signaling of apoptosis in aging and autoimmunity
    • Structure, function and pathogenetic significance of Ro ribonucleoproteins
    • NKT cell biology; their mechanisms in disease control
    • Antiendothelial cell antibodies, with special emphasis on HSP-60

  4. TOLERANCE
    • Mechanisms of immune tolerance
    • Mechanisms and promise of immune tolerance in therapy of SLE
    • Tolerance deficits that are of most relevance to human autoimmunity
    • Mucosal tolerance for the treatment of autoimmune diseases
    • Natural autoimmunity
    • Differences in tolerance mechanisms in the T and B cell compartments
    • Susceptibility/resistance to autoimmunity
    • Nuclear molecules as mediators of inflammation

  5. DIAGNOSTICS
    • Peptides as autoantigens
    • Novel recombinant autoantigens
    • Micro-array technology for probing the immune system
    • Tetramers for detection of autoreactive T cells
    • New technologies in the detection of autoantibodies especially antigen arrays and addressable laser beads
    • Novel autoantigens in neurological diseases: diagnostic and pathogenic considerations
    • Challenges for the clinical autoantibody laboratory
    • Algorithms in autoimmunity diagnostics
    • Immune informatics
    • Definition of autoimmune epitopes
    • Prediction and prevention of type 1 diabetes
    • Antinucleophosmin antibodies in murine and human SLE
    • Anti-glycan approach
    • IBD/MS indications
  6. HORMONAL
    • Autoimmunity and pregnancy
    • Pregnancy and lupus/antiphospholipid syndrome
    • Sex-based differences
    • The role of glucocorticoid hormones in T cell differentiation and selection
    • Pregnancy and connective tissue diseases

  7. INFECTION
    • Infectious components and autoimmunity and/or mucosal immunity and autoimmunity
    • Microbial B cell super antigens and their potential to cause inflammation
    • Vaccination and autoimmunity
    • Adjuvant and autoimmunity
    • Coxsackie viruses and autoimmune epithelitis
    • The role of commensal bacteria in inflammation and autoimmunity

  8. ANIMAL MODELS
    • Animal models of vasculitis and glomerulonephritis
    • New knockout mice

  9. DISEASES
    • Atherosclerosis and autoimmunity
    • Vasculitis
    • Sjøgren's disease
    • Monoclonal thyroid stimulating antibodies and thyroid autoimmunity
    • The cellular and molecular basis of primary biliary cirrhosis
    • Antiphospholipid Abs in reproductive failure/infertility
    • Antiphospholipid antibody and mechanism of the thrombus formation
    • Rheumatoid arthritis as a paradigm of new therapies for autoimmune disorders
    • The role of the thymus in myasthenia gravis
    • Autoimmune hepatitis
    • Pemphigus vulgaris
    • Autoimmune bullous dermatoses
    • Systemic autoimmune diseases presenting with skin symptoms
    • Borderline, ligand diseases between autoimmunity and different fields of dermatology
    • Allergy and autoimmunity
    • The associations between different autoimmune diseases
    • Multiple sclerosis and regulatory cells
    • Neuroimmunology
    • Early microvascular changes in scleroderma
    • The role of antibody and B cells in rheumatoid arthritis
    • Autoimmunity associated with immune deficiency diseases
    • Paraneoplastic autoimmunity
    • Type 1 diabetes
    • Immunology of cardiovascular disease
    • The role of thrombin in autoimmune neurological disease
    • Autoimmunity to HSP and ox-LDL in atherosclerosis/vasculitis
    • Cognition and autoimmunity
    • Therapy of ANCA-associated vasculitis
    • Inflammatory clearance of apoptotic cells in vasculitis and lupus
    • Immunoendocrine changes in healthy subjects and SLE patients during pregnancy
    • Pulmonary hypertension in scleroderma
    • Autoimmunity in the central nervous system
    • Autoimmunity to endothelial cells – from scleroderma to atherosclerosis
    • Cardiovascular involvement in rheumatic diseases
    • B cells and primary biliary cirrhosis
    • B cell clonality in Sjøgren’s Syndrome: histopathological analysis and response to rituximab
    • Snow white duodenum as an underlying disease in autoimmune
    • Immune reactions against silicone implants

  10. THERAPY
    • IVIG
    • Gene therapy and autoimmune disease
    • Wheat as a source of compounds against cancer and autoimmune diseases
    • Peptide therapy for autoimmune disease
    • Adoptive cellular gene therapy of autoimmune disease
    • Immunopoiesis, transplantation and the treatment of autoimmunity
    • Remodelling in systemic autoimmune diseases by differentiated stem cells or gene therapy
    • Clinical and management aspects of SLE
    • Therapeutic vaccines for autoimmune disease, T cell vaccination, drug- vaccines against
    • myasthenia gravis, drugs-vaccines against lupus
    • Statins in treatment of autoimmune disease
    • Novel biologics in autoimmune disorders
    • Cellcept – an advance in the treatment of lupus nephritis
    • Use of monocloral therapy for the treatment of uveitis
    • Leflunomide-induced lung injury
    • Therapeutic strategies in systemic necrotizing vasculitis

  11. PROGNOSIS
    • Predicting autoimmunity
    • Preventive measurements in autoimmunity
    • Clinical activity indexes

  12. CANCER
    • Tumor-associated autoantibodies as indicators of cancer development
    • Nutraceuticals in supportive treatment of cancer and autoimmune diseases
    • Lymphoma and autoimmune rheumatic diseases

  13. PATIENTS SESSIONS
    • Special sessions for patients will take place with lectures by experts in various fields of autoimmune diseases.
    • Supported by American Autoimmune Related Diseases Association (AARDA) and Associazione Patologie Autoimmuni Internazionale (APAI).
Home | Welcome Note | Committees | Preliminary Timetable | General Information | CME accreditation | Preliminary Topics | Registration | Transportation | Accommodation | Social Events | Accompanying Person Program | Optional Congress Tour | Sponsorship & Exhibition | Sponsors | Satellites & Related Meetings | Autoimmunity Review Journal
Italian agent for Italian companies